Developer docs
API playgroundTry for free, no card

Search company profiles

Dômes Pharma

Full company profile

uuid02i19pu

Namestring
Dômes Pharma
Legal namestring
TVM UK Animal Health Ltd.
Websiteurl
tvm-uk.com
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Dômes Pharma, the trading name of TVM UK Animal Health Ltd., is a privately held UK veterinary pharmaceutical company headquartered in Kirtlington, Oxfordshire. The company focuses on specialty animal health products across several niche therapeutic categories: emergency poisoning treatment (Anti-Tox Range, Carbodote Range), pet anxiety management (Tessie® for situational anxiety in dogs, Bonqat® for transport/vet-visit anxiety), ocular health (OphtaPRIME® and Remend® BioHAnce™ Corneal Gel under the Corneal Focus Range), epilepsy management (Epilepsy System), and stem cell-based regenerative treatments.

The company's business model is built on direct sales of pharmaceutical products to UK veterinary practices through a network of Territory Managers who visit clinics in person, supplemented by Lunch and Learn educational sessions. Revenue is generated through prescription and administration of these products by veterinary professionals to pet owners (end consumers). Pricing is quote-based and not publicly disclosed, consistent with a B2B veterinary distribution model. The company pairs its product portfolio with a substantial education and content ecosystem — the Vet Vault resource library, the Synaptic Tails neurology podcast, 3D Ocular Immersion tools, and sponsored CPD webinars via WebinarVet — that targets veterinary professionals as the primary decision-makers while also reaching pet owners through dedicated sites such as myepilepticpet.co.uk. The company serves a single-country UK market, with no disclosed international operations, subsidiaries, M&A activity, or institutional funding.

Short descriptiontext

Dômes Pharma (trading as TVM UK Animal Health Ltd.) is a UK-based specialty veterinary pharmaceutical company that sells niche animal health products — including anti-toxins, anxiety treatments (Tessie®, Bonqat®), ocular care, and epilepsy and stem cell therapies — directly to veterinary practices via a Territory Manager field sales force, supported by an educational content ecosystem (Vet Vault, CPD webinars, podcasts).

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersKirtlington, United Kingdom
HQ citystring
Kirtlington
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
veterinary pharmaceuticals, animal health products, pet medications, veterinary supplies, companion animal care
Industry3 codes
PRIMARYHLAMAIAH
Specialty Veterinary Therapeutics Distribution (Oncology, Dermatology, Endocrinology)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Distribution & Retail (Wholesalers, Pharmacies)
SECONDARYHLAMAIAA
Veterinary Pharmaceutical Wholesalers & Distributors
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Distribution & Retail (Wholesalers, Pharmacies)
SECONDARYAFAEANAK
Veterinary Pharmacy, Vaccine & Biologics Services
NAICS code2 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Biological Product (except Diagnostic) Manufacturing325414
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Veterinary Pharmaceuticals
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Pharmaceutical Product Sales
TypeOne Time License
Description

Dômes Pharma generates revenue through the sale of specialized veterinary pharmaceutical products across multiple therapeutic categories including anti-toxins, anxiety treatments, ocular health, and epilepsy management. Products are sold to veterinary practices who then administer or prescribe to pet owners.

domespharma.co.uk
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Supply Chain, Marketing or Sales, Technology or R&D, Operations
Pricing details1 tier
1Veterinary pharmaceutical products - pricing available upon verification
ModelOtherBilling cadencePay-as-you-go
Notes

Quote-based / Not publicly disclosed

domespharma.co.uk
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Dômes Pharma develops and distributes a portfolio of specialist veterinary pharmaceutical products for companion animals across therapeutic areas including anti-poisoning, anxiety, ocular health, epilepsy management, and regenerative stem cell therapy. The company sells these products to UK veterinary practices through a direct field-sales network of Territory Managers, and supplements the product range with a comprehensive veterinary education platform (Vet Vault) including CPD webinars, podcasts, and resource libraries.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Dômes Pharma is an innovative animal health company offering a portfolio of veterinary pharmaceutical products organized into specialist ranges. The product portfolio includes the Anxiety Range (Tessie® for situational anxiety in dogs, Bonqat® for acute anxiety during transportation/veterinary visits), Corneal Focus Range (OphtaPRIME® as a 3-in-1 ocular treatment prequel, Remend® BioHAnce™ Corneal Gel for ocular injury healing), Anti-Tox Range for poisoning cases, Carbodote Range for poisoning management, Epilepsy System for epilepsy management, and Stem Cells for advanced treatments. The company serves both veterinary professionals and pet owners, providing specialized pharmaceutical solutions across multiple therapeutic areas.

Product and service8 records
1Tessie®
CategoryVeterinary Pharmaceuticals — Anxiety Treatment
Description

Veterinary pharmaceutical for the short-term alleviation of situational anxiety and fear in dogs triggered by noise or owner departure. Marketed as a newer arrival within the Anxiety Range for veterinary professionals.

2Bonqat®
CategoryVeterinary Pharmaceuticals — Anxiety Treatment
Description

Veterinary pharmaceutical for the alleviation of acute anxiety and fear associated with transportation and veterinary visits in companion animals. Marketed as a newer arrival within the Anxiety Range for veterinary professionals.

3OphtaPRIME®
CategoryVeterinary Pharmaceuticals — Ocular Health
Description

Ocular treatment product positioned as a 3-in-1 prequel to ocular treatment within the Corneal Focus Range, for use by veterinary professionals on companion animal patients.

4Remend® BioHAnce™ Corneal Gel
CategoryVeterinary Pharmaceuticals — Ocular Health
Description

Ocular gel that aids the healing of ocular injuries in pets, based on BioHAnce technology. Part of the Corneal Focus Range, intended for veterinary professional use.

5Anti-Tox Range
CategoryVeterinary Pharmaceuticals — Poisoning Treatment
Description

Range of veterinary pharmaceutical products designed to prepare practices for poisoning cases in companion animals. Sold to UK veterinary practices for clinical use.

6Carbodote Range
CategoryVeterinary Pharmaceuticals — Poisoning Treatment
Description

Range of activated charcoal-based veterinary pharmaceutical products for the management of poisoning cases in companion animals. Sold to UK veterinary practices.

7Epilepsy System
CategoryVeterinary Pharmaceuticals — Neurology
Description

Comprehensive epilepsy management offering for pets, providing veterinary practices with a system for managing canine and feline epilepsy cases.

8Stem Cells
CategoryVeterinary Pharmaceuticals — Regenerative Medicine
Description

Stem cell-based regenerative medicine treatment offering for animal health, supplied to veterinary practices as an advanced therapeutic option.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeGTM or Marketing Partner
Description

Dômes Pharma sponsors CPD (Continuing Professional Development) content on the WebinarVet platform. The company provides sponsored webinars covering topics such as ophthalmology and stem cells, positioning the brand in front of veterinary professionals through educational content.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global animal-health company with companion-animal pharmaceutical portfolio (including behavioural and dermatology products) sold to veterinary clinics; broader and deeper product set than Dômes Pharma but overlapping customer base in UK vet practices.

TypeDirect peer
Description

Northern Ireland-based veterinary pharmaceutical manufacturer focused on companion- and production-animal medicines; directly comparable UK & Ireland specialty pharma operating with similar channel and regulatory dynamics.

TypeDirect peer
Description

French global veterinary pharmaceutical company with a broad companion-animal specialty portfolio (anxiety, dermatology, cardiology); closely comparable in therapeutic breadth, European footprint and veterinary-clinic go-to-market approach.

TypeDirect peer
Description

French-listed veterinary pharmaceutical company focused on companion animals; comparable specialty/niche therapeutic portfolio (including neurology, dermatology, ophthalmology) sold to veterinary clinics with field sales teams across Europe, including the UK.

5TVM (Laboratoire TVM)
TypeDirect peer
Description

Parent French veterinary pharmaceutical laboratory whose UK arm operates as 'Dômes Pharma / TVM UK Animal Health Ltd.'; same therapeutic categories, R&D pipeline, and corporate history, providing the closest product-by-product comparability.

TypeBroad incumbent
Description

Largest global animal-health company with deep companion-animal pharmaceutical portfolio covering dermatology, neurology and ophthalmology; significant competitor in UK vet practices and the dominant incumbent against whom all specialty pharma peers position themselves.

TypeDirect peer
Description

UK-headquartered specialty veterinary pharmaceuticals company (acquired by EQT in 2024) selling branded niche therapeutics through veterinary practices; nearly identical target customer, distribution model and therapeutic specialisation profile to Dômes Pharma's UK operations.

TypeBroad incumbent
Description

Global French-headquartered animal-health company with companion-animal pharmaceuticals (including neurology and behavioural products) distributed to veterinary practices worldwide; broader portfolio and global scale but overlapping specialty territory.

TypeDirect peer
Description

UK-listed (now EQT-owned) veterinary pharmaceutical company supplying niche therapeutics to UK and European vet practices; very similar specialty-pharma positioning and product mix orientation as Dômes Pharma.

10Boehringer Ingelheim Animal Health
TypeBroad incumbent
Description

Top-3 global animal-health player with broad veterinary pharmaceutical and biological offerings distributed through vet practices; competitor in many of the same therapeutic categories (e.g. ophthalmology) and the broad-incumbent benchmark Dômes Pharma must position against.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Dômes Pharma

Veterinary Pharmaceuticalstvm-uk.com

Dômes Pharma (trading as TVM UK Animal Health Ltd.) is a UK-based specialty veterinary pharmaceutical company that sells niche animal health products — including anti-toxins, anxiety treatments (Tessie®, Bonqat®), ocular care, and epilepsy and stem cell therapies — directly to veterinary practices via a Territory Manager field sales force, supported by an educational content ecosystem (Vet Vault, CPD webinars, podcasts).

What Dômes Pharma does

Dômes Pharma, the trading name of TVM UK Animal Health Ltd., is a privately held UK veterinary pharmaceutical company headquartered in Kirtlington, Oxfordshire. The company focuses on specialty animal health products across several niche therapeutic categories: emergency poisoning treatment (Anti-Tox Range, Carbodote Range), pet anxiety management (Tessie® for situational anxiety in dogs, Bonqat® for transport/vet-visit anxiety), ocular health (OphtaPRIME® and Remend® BioHAnce™ Corneal Gel under the Corneal Focus Range), epilepsy management (Epilepsy System), and stem cell-based regenerative treatments.

The company's business model is built on direct sales of pharmaceutical products to UK veterinary practices through a network of Territory Managers who visit clinics in person, supplemented by Lunch and Learn educational sessions. Revenue is generated through prescription and administration of these products by veterinary professionals to pet owners (end consumers). Pricing is quote-based and not publicly disclosed, consistent with a B2B veterinary distribution model. The company pairs its product portfolio with a substantial education and content ecosystem — the Vet Vault resource library, the Synaptic Tails neurology podcast, 3D Ocular Immersion tools, and sponsored CPD webinars via WebinarVet — that targets veterinary professionals as the primary decision-makers while also reaching pet owners through dedicated sites such as myepilepticpet.co.uk. The company serves a single-country UK market, with no disclosed international operations, subsidiaries, M&A activity, or institutional funding.

Dômes Pharma firmographics

Firmographics
Name
Dômes Pharma
Legal name
TVM UK Animal Health Ltd.
Website
https://tvm-uk.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
11–50 employees
Short description
Dômes Pharma (trading as TVM UK Animal Health Ltd.) is a UK-based specialty veterinary pharmaceutical company that sells niche animal health products — including anti-toxins, anxiety treatments (Tessie®, Bonqat®), ocular care, and epilepsy and stem cell therapies — directly to veterinary practices via a Territory Manager field sales force, supported by an educational content ecosystem (Vet Vault, CPD webinars, podcasts).
Ownership category
akta.pro rank

Dômes Pharma industry classification

Industry
Product category
Veterinary Pharmaceuticals
NAICS
Pharmaceutical Preparation Manufacturing (325412), Biological Product (except Diagnostic) Manufacturing (325414)
SIC
Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYHLAMAIAH
Specialty Veterinary Therapeutics Distribution (Oncology, Dermatology, Endocrinology)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Distribution & Retail (Wholesalers, Pharmacies)
SECONDARYHLAMAIAA
Veterinary Pharmaceutical Wholesalers & Distributors
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Distribution & Retail (Wholesalers, Pharmacies)
SECONDARYAFAEANAK
Veterinary Pharmacy, Vaccine & Biologics Services

Keywords

  • Veterinary pharmaceuticals
  • Animal health products
  • Pet medications
  • Veterinary supplies
  • Companion animal care

Where Dômes Pharma is headquartered

Location

Headquarters

HQ city
Kirtlington
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

Dômes Pharma business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Supply Chain, Marketing or Sales, Technology or R&D, Operations

Revenue model

  1. Pharmaceutical Product Sales: Dômes Pharma generates revenue through the sale of specialized veterinary pharmaceutical products across multiple therapeutic categories including anti-toxins, anxiety treatments, ocular health, and epilepsy management. Products are sold to veterinary practices who then administer or prescribe to pet owners.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goVeterinary pharmaceutical products - pricing available upon verification

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Dômes Pharma product offering

Product offering

Core offering

Dômes Pharma develops and distributes a portfolio of specialist veterinary pharmaceutical products for companion animals across therapeutic areas including anti-poisoning, anxiety, ocular health, epilepsy management, and regenerative stem cell therapy. The company sells these products to UK veterinary practices through a direct field-sales network of Territory Managers, and supplements the product range with a comprehensive veterinary education platform (Vet Vault) including CPD webinars, podcasts, and resource libraries.

Product overview

Dômes Pharma is an innovative animal health company offering a portfolio of veterinary pharmaceutical products organized into specialist ranges. The product portfolio includes the Anxiety Range (Tessie® for situational anxiety in dogs, Bonqat® for acute anxiety during transportation/veterinary visits), Corneal Focus Range (OphtaPRIME® as a 3-in-1 ocular treatment prequel, Remend® BioHAnce™ Corneal Gel for ocular injury healing), Anti-Tox Range for poisoning cases, Carbodote Range for poisoning management, Epilepsy System for epilepsy management, and Stem Cells for advanced treatments. The company serves both veterinary professionals and pet owners, providing specialized pharmaceutical solutions across multiple therapeutic areas.

Differentiator

Problem solved

Functional benefit

Products and services

  • Tessie® Veterinary pharmaceutical for the short-term alleviation of situational anxiety and fear in dogs triggered by noise or owner departure. Marketed as a newer arrival within the Anxiety Range for veterinary professionals.
  • Bonqat® Veterinary pharmaceutical for the alleviation of acute anxiety and fear associated with transportation and veterinary visits in companion animals. Marketed as a newer arrival within the Anxiety Range for veterinary professionals.
  • OphtaPRIME® Ocular treatment product positioned as a 3-in-1 prequel to ocular treatment within the Corneal Focus Range, for use by veterinary professionals on companion animal patients.
  • Remend® BioHAnce™ Corneal Gel Ocular gel that aids the healing of ocular injuries in pets, based on BioHAnce technology. Part of the Corneal Focus Range, intended for veterinary professional use.
  • Anti-Tox Range Range of veterinary pharmaceutical products designed to prepare practices for poisoning cases in companion animals. Sold to UK veterinary practices for clinical use.
  • Carbodote Range Range of activated charcoal-based veterinary pharmaceutical products for the management of poisoning cases in companion animals. Sold to UK veterinary practices.
  • Epilepsy System Comprehensive epilepsy management offering for pets, providing veterinary practices with a system for managing canine and feline epilepsy cases.
  • Stem Cells Stem cell-based regenerative medicine treatment offering for animal health, supplied to veterinary practices as an advanced therapeutic option.

Companies that use Dômes Pharma

Customer profile

Segments2 records

Ideal customer profiles1 record

Dômes Pharma technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Dômes Pharma partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • WebinarVetcoreGTM or Marketing PartnerDômes Pharma sponsors CPD (Continuing Professional Development) content on the WebinarVet platform. The company provides sponsored webinars covering topics such as ophthalmology and stem cells, positioning the brand in front of veterinary professionals through educational content.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Dômes Pharma competitors and assessment

Company assessment

Broad incumbents

  • Elanco Animal Health: Global animal-health company with companion-animal pharmaceutical portfolio (including behavioural and dermatology products) sold to veterinary clinics; broader and deeper product set than Dômes Pharma but overlapping customer base in UK vet practices.
  • Zoetis: Largest global animal-health company with deep companion-animal pharmaceutical portfolio covering dermatology, neurology and ophthalmology; significant competitor in UK vet practices and the dominant incumbent against whom all specialty pharma peers position themselves.
  • Ceva Santé Animale: Global French-headquartered animal-health company with companion-animal pharmaceuticals (including neurology and behavioural products) distributed to veterinary practices worldwide; broader portfolio and global scale but overlapping specialty territory.
  • Boehringer Ingelheim Animal Health: Top-3 global animal-health player with broad veterinary pharmaceutical and biological offerings distributed through vet practices; competitor in many of the same therapeutic categories (e.g. ophthalmology) and the broad-incumbent benchmark Dômes Pharma must position against.

Direct peers

  • Norbrook Laboratories: Northern Ireland-based veterinary pharmaceutical manufacturer focused on companion- and production-animal medicines; directly comparable UK & Ireland specialty pharma operating with similar channel and regulatory dynamics.
  • Virbac: French global veterinary pharmaceutical company with a broad companion-animal specialty portfolio (anxiety, dermatology, cardiology); closely comparable in therapeutic breadth, European footprint and veterinary-clinic go-to-market approach.
  • Vetoquinol: French-listed veterinary pharmaceutical company focused on companion animals; comparable specialty/niche therapeutic portfolio (including neurology, dermatology, ophthalmology) sold to veterinary clinics with field sales teams across Europe, including the UK.
  • TVM (Laboratoire TVM): Parent French veterinary pharmaceutical laboratory whose UK arm operates as 'Dômes Pharma / TVM UK Animal Health Ltd.'; same therapeutic categories, R&D pipeline, and corporate history, providing the closest product-by-product comparability.
  • Dechra Pharmaceuticals: UK-headquartered specialty veterinary pharmaceuticals company (acquired by EQT in 2024) selling branded niche therapeutics through veterinary practices; nearly identical target customer, distribution model and therapeutic specialisation profile to Dômes Pharma's UK operations.
  • Animalcare Group: UK-listed (now EQT-owned) veterinary pharmaceutical company supplying niche therapeutics to UK and European vet practices; very similar specialty-pharma positioning and product mix orientation as Dômes Pharma.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Dômes Pharma social profiles

Digital presence

Dômes Pharma financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Dômes Pharma leadership team

Management profile

Number of profiles

Dômes Pharma funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Dômes Pharma M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dômes Pharma

What does Dômes Pharma do?

Dômes Pharma develops and distributes a portfolio of specialist veterinary pharmaceutical products for companion animals across therapeutic areas including anti-poisoning, anxiety, ocular health, epilepsy management, and regenerative stem cell therapy. The company sells these products to UK veterinary practices through a direct field-sales network of Territory Managers, and supplements the product range with a comprehensive veterinary education platform (Vet Vault) including CPD webinars, podcasts, and resource libraries.

Is Dômes Pharma a public or private company?

Dômes Pharma is a private company. It is classified as unknown and is currently operating.

When was Dômes Pharma founded?

Dômes Pharma was founded in 2017. It employs 11 to 50 people.

Where is Dômes Pharma based?

Dômes Pharma is headquartered in Kirtlington, United Kingdom, in the Europe region.

How does Dômes Pharma make money?

One revenue line is on record: pharmaceutical Product Sales.

Who are Dômes Pharma's main competitors?

Broad incumbents on record are Elanco Animal Health, Zoetis, Ceva Santé Animale and Boehringer Ingelheim Animal Health. Direct peers are Norbrook Laboratories, Virbac, Vetoquinol, TVM (Laboratoire TVM), Dechra Pharmaceuticals and Animalcare Group.

Does Dômes Pharma have an API?

No public API is recorded for Dômes Pharma.

What industry is Dômes Pharma in?

Dômes Pharma's product category is Veterinary Pharmaceuticals. Its primary akta.pro industry code is HLAMAIAH, Specialty Veterinary Therapeutics Distribution (Oncology, Dermatology, Endocrinology), with a secondary code of HLAMAIAA, Veterinary Pharmaceutical Wholesalers & Distributors. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals